Skip to content
News
Non Regulatory

Nanoform’s positive commercial momentum continues

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Press release
Regulatory

Erbjudandet i samband med noteringen av Nanoform har kraftigt övertecknats och kommer att genomföras som planerat – handel i aktierna förväntas inledas imorgon

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.

News
Regulatory

Nanoform Finland Plc har ansökt om upptagande till handel av dess aktier på Nasdaq First North Premier Growth Market Finland och Nasdaq First North Premier Growth Market Sweden

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.

News

A message from Nanoform regarding COVID-19

The COVID-19 pandemic is evolving rapidly, and we would like to assure our customers, partners, and suppliers that we are diligently monitoring the situation and follow the most up-to-date World Health Organization, EU, and local government guidelines.

News
Non Regulatory

Nanoform files for GMP certification

Nanoform has filed for GMP status with the Finnish Medicines Agency, FIMEA. The drug substance application for GMP clinical manufacture certification exemplifies its progress and growth in the last 12 months.

News
Non Regulatory

Nanoform strengthens board with appointment of Mads Laustsen

Nanoform has appointed Mads Laustsen as a non-executive board member. This appointment will further strengthen the experienced Nanoform board and support the company as it increases its ability to deliver nanonized APIs for global partners across the pipeline from late stage drug discovery to commercial.

News
Non Regulatory

Nanoform announces major rebrand

Nanoform has unveiled a new brand identity and website. The evolution of Nanoform’s brand reflects how the company is using innovation to transform the pharmaceutical industry and support its global partners as they develop life-changing medicines.